FDA — authorised 16 April 2014
- Application: ANDA200910
- Marketing authorisation holder: MYLAN TECHNOLOGIES
- Local brand name: XULANE
- Indication: FILM, EXTENDED RELEASE — TRANSDERMAL
- Status: approved
🇺🇸 Transdermal Contraceptive in United States
FDA authorised Transdermal Contraceptive on 16 April 2014
Marketing authorisation
Other Contraception / Reproductive Health approved in United States
Frequently asked questions
Is Transdermal Contraceptive approved in United States?
Yes. FDA authorised it on 16 April 2014.
Who is the marketing authorisation holder for Transdermal Contraceptive in United States?
MYLAN TECHNOLOGIES holds the US marketing authorisation.